SPONSOR
Ottawa Heart Institute Research Corporation
Total Trials
4
Recruiting
4
Phases
Phase 3, Phase 4
Conditions studied: ST Elevation Myocardial InfarctionMyocardial InfarctionThoracic Aortic DiseaseTobaccoShock, Cardiogenic
Ottawa Heart Institute Research Corporation is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including ST Elevation Myocardial Infarction, Myocardial Infarction, Thoracic Aortic Disease, Tobacco.
The trial portfolio spans Phase 3, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Ottawa Heart Institute Research Corporation
How many clinical trials has Ottawa Heart Institute Research Corporation sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Ottawa Heart Institute Research Corporation, of which 4 are actively recruiting participants. These trials cover conditions including ST Elevation Myocardial Infarction, Myocardial Infarction, Thoracic Aortic Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Ottawa Heart Institute Research Corporation research focus on?
Ottawa Heart Institute Research Corporation clinical trials span ST Elevation Myocardial Infarction, Myocardial Infarction, Thoracic Aortic Disease, Tobacco, Shock, Cardiogenic. The research pipeline includes Phase 3, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Ottawa Heart Institute Research Corporation clinical trial?
To participate in a Ottawa Heart Institute Research Corporation trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Ottawa Heart Institute Research Corporation trials with current recruitment status updated daily.
Clinical Trials by Ottawa Heart Institute Research Corporation
NCT06174753 Phase 3
Recruiting
Dapagliflozin in STEMI
ST Elevation Myocardial Infarction
NCT02860364
Recruiting
Comparing Hypothermic Temperatures During Hemiarch Surgery
Thoracic Aortic Disease
NCT06832085 Phase 4
Recruiting
Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation
Tobacco
NCT05267886 Phase 4
Recruiting
CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
Shock, Cardiogenic
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology